110 related articles for article (PubMed ID: 24715283)
1. Development of antibiotic-free selection system for safer DNA vaccination.
Luke JM; Carnes AE; Williams JA
Methods Mol Biol; 2014; 1143():91-111. PubMed ID: 24715283
[TBL] [Abstract][Full Text] [Related]
2. Multivalent DNA-based vectors for DNA vaccine delivery.
Roh YH; Lee K; Ye JJ; Luo D
Methods Mol Biol; 2014; 1143():159-79. PubMed ID: 24715288
[TBL] [Abstract][Full Text] [Related]
3. Improving DNA vaccine performance through vector design.
Williams JA
Curr Gene Ther; 2014; 14(3):170-89. PubMed ID: 25142448
[TBL] [Abstract][Full Text] [Related]
4. A blueprint for DNA vaccine design.
Iurescia S; Fioretti D; Rinaldi M
Methods Mol Biol; 2014; 1143():3-10. PubMed ID: 24715278
[TBL] [Abstract][Full Text] [Related]
5. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.
Dietrich G; Spreng S; Favre D; Viret JF; Guzman CA
Curr Opin Mol Ther; 2003 Feb; 5(1):10-9. PubMed ID: 12669465
[TBL] [Abstract][Full Text] [Related]
6. Strategies for improving DNA vaccine performance.
Iurescia S; Fioretti D; Rinaldi M
Methods Mol Biol; 2014; 1143():21-31. PubMed ID: 24715280
[TBL] [Abstract][Full Text] [Related]
7. Critical design criteria for minimal antibiotic-free plasmid vectors necessary to combine robust RNA Pol II and Pol III-mediated eukaryotic expression with high bacterial production yields.
Carnes AE; Luke JM; Vincent JM; Anderson S; Schukar A; Hodgson CP; Williams JA
J Gene Med; 2010 Oct; 12(10):818-31. PubMed ID: 20806425
[TBL] [Abstract][Full Text] [Related]
8. Bacterial systems for the delivery of eukaryotic antigen expression vectors.
Dietrich G; Spreng S; Gentschev I; Goebel W
Antisense Nucleic Acid Drug Dev; 2000 Oct; 10(5):391-9. PubMed ID: 11079578
[TBL] [Abstract][Full Text] [Related]
9. pDNAVACCultra vector family: high throughput intracellular targeting DNA vaccine plasmids.
Williams JA; Luke J; Johnson L; Hodgson C
Vaccine; 2006 May; 24(21):4671-6. PubMed ID: 16448726
[TBL] [Abstract][Full Text] [Related]
10. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
[TBL] [Abstract][Full Text] [Related]
11. Intradermal vaccination by DNA tattooing.
van den Berg JH; Oosterhuis K; Schumacher TN; Haanen JB; Bins AD
Methods Mol Biol; 2014; 1143():131-40. PubMed ID: 24715286
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccination: antigen presentation and the induction of immunity.
Shedlock DJ; Weiner DB
J Leukoc Biol; 2000 Dec; 68(6):793-806. PubMed ID: 11129646
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of antigen-specific immune responses using DNA-fusogenic liposome vaccine.
Yoshikawa T; Imazu S; Gao JQ; Hayashi K; Tsuda Y; Shimokawa M; Sugita T; Niwa T; Oda A; Akashi M; Tsutsumi Y; Mayumi T; Nakagawa S
Biochem Biophys Res Commun; 2004 Dec; 325(2):500-5. PubMed ID: 15530420
[TBL] [Abstract][Full Text] [Related]
14. Use of attenuated bacteria as delivery vectors for DNA vaccines.
Daudel D; Weidinger G; Spreng S
Expert Rev Vaccines; 2007 Feb; 6(1):97-110. PubMed ID: 17280482
[TBL] [Abstract][Full Text] [Related]
15. Enhanced CTL response by controlled intracellular trafficking of antigen in dendritic cells following DNA vaccination.
Isaji K; Kawase A; Matono M; Guan X; Nishikawa M; Takakura Y
J Control Release; 2009 May; 135(3):227-33. PubMed ID: 19331843
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms for enhanced DNA vaccine immunogenicity.
Li L; Petrovsky N
Expert Rev Vaccines; 2016; 15(3):313-29. PubMed ID: 26707950
[TBL] [Abstract][Full Text] [Related]
18. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
19. A Hybrid Biological-Biomaterial Vector for Antigen Delivery.
Qi R; Hill A; Pfeifer BA
Methods Mol Biol; 2021; 2183():461-475. PubMed ID: 32959260
[TBL] [Abstract][Full Text] [Related]
20. Progresses in DNA-based heterologous prime-boost immunization strategies.
Jackson RJ; Boyle DB; Ranasinghe C
Methods Mol Biol; 2014; 1143():61-90. PubMed ID: 24715282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
